Management of Citalopram-Induced Hypomania

Immediate Management Strategy

• Gradual tapering of SSRIs is essential to avoid withdrawal symptoms and prevent rebound worsening of symptoms, as recommended by the American Academy of Child and Adolescent Psychiatry 1, 2, 3
• The American Academy of Pediatrics recommends that citalopram should not be abruptly stopped, as abrupt discontinuation of antidepressants can lead to withdrawal effects and potentially worsen mood instability 4

Practical Implementation

• The American Academy of Family Physicians recommends beginning lithium at 150 mg/day, which is an appropriate starting dose for mood stabilization 5
• The American Academy of Pediatrics suggests reducing the citalopram dose, for example, if on 20-40 mg, reduce by 50% initially rather than stopping completely 4
• The WHO recommends that lithium should only be initiated in those settings where personnel and facilities for close clinical and laboratory monitoring are available, as stated in PLoS Medicine 6, 7

Monitoring Requirements

• The American Academy of Child and Adolescent Psychiatry recommends a baseline laboratory assessment before lithium, including complete blood count, thyroid function tests, urinalysis, blood urea nitrogen, creatinine, serum calcium, and pregnancy test in females 8

Evidence-Based Rationale

• The American Academy of Child and Adolescent Psychiatry encourages prescribers to taper medication slowly to avoid withdrawal symptoms or rebound worsening of symptoms 1, 2, 3
• The WHO guidelines recommend that lithium, valproate, or carbamazepine should be offered to individuals with bipolar mania, as stated in PLoS Medicine 6, 7

Common Pitfalls to Avoid

• The American Academy of Child and Adolescent Psychiatry and the American Academy of Pediatrics recommend not abruptly discontinuing citalopram, as this increases the risk of withdrawal symptoms and mood destabilization 1, 2, 3, 4
• The WHO recommends not delaying mood stabilizer initiation, as the hypomania requires immediate treatment with appropriate mood stabilization, as stated in PLoS Medicine 6, 7
• The American Academy of Child and Adolescent Psychiatry recommends not starting lithium without proper monitoring capabilities, as lithium requires close clinical and laboratory monitoring 6, 7, 8